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Colposcopy for early stage cevical cancer 
Alemka Brnčić-Fischer 
During the past decades, the incidence of cervical carcinoma in industrial-
ized countries has decreased. This decrease is, however, restricted to cervical 
squamous cell carcinoma, whereas the incidence of AC and its precursor AIS 
has remained stable or increased (1). In 1952. 4,5% of all cervical cancers 
were Acs (2). Nowadays, this percentage has risen to 20% (3). 
The term preclinical invasive cancer is applied to very early invasive cancers 
(e.g., stage 1) in women without symptoms and gross physical findings and 
clinical signs, that are diagnosed incidentally during colposcopy or by other 
early-detection approaches such as screening. 
The primary responsibility of a colposcopist is to ensure that if preclinical 
invasive carcinoma of the cervix is present in a woman, it will be diagnosed.  
Missing a cervical cancer has seroius ramifications, for both the patient and 
clinician. It happens because of any of several potential inadequacies (4): 
1) an inadequate case load (i.e., not enough patients to develod an 
adequate level of expertise) 
2) a poor understanding of the disease processes 
3) deviation from or deficiensis in a diagnostic protocol 
4) insufficient biopses (i.e., too small, no stroma, inadequate number) or 
samples frpm the wrong sites 
5) failure to perform an ECC when indicated 
6) failute to excise when ECC is positive 
7)cervical ablation without prior biopsy 
8) failure to correlate cytologic, colposcopic, anf histologic findings 
9) failure to appreciate the indications for excision 
10) misscommunication with the pathologist 
The incidence of microinvasive and occult invasive cancers increases as 
women grow older. The incidence begins to gradually rise in the late 20s, 
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reaching a pleateau in the 40s, and peaking in the late 50s (5). While increa-
sing age increases the risk of invasive cancer, the risk for colposcopist in 
missing cancer may be greatest for young women with cancer because of its 
extreme rarity.  
Large high-grade lesions, involving more than three quadrants of the cervix, 
should be thoroughly investigated for the possibility of early invasive cancer, 
especially if associated with atypical vessels. Other warning signs include the 
presence of a wide abnormal transformation zone (greater than 40 mm2), 
complex acetowhite lesions involving both lips of the cervix, lesions oblite-
rating the os, lesions with irregular and exophytic surface contour, strikingly 
thick chalky white lesions with raised and rolled out margins, strikingly 
excessive atypical vessels, bleeding on touch or the presence of symptoms 
such as vaginal bleeding. 
One of the earliest colposcopic signs of possible invasion is blood vessels 
breaking out from the mosaic formations and producing irregular longitudi-
nal vessels. As the neoplastic process closely approaches the stage of invasive 
cancer, the blood vessels can take on increasingly irregular, bizarre patterns. 
Appearance of atypical vessels usually indicates the first signs of invasion. 
The key characteristics of these atypical surface vessels are that there is no 
gradual decrease in calibre (tapering) in the terminal branches and that the 
regular branching, seen in normal surface vessels, is absent.  
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Early preclinical invasive cancer may also appear as dense, thick, chalky-
white areas with surface irregularity and nodularity and with raised and 
rolled out margins . Such lesions may not present atypical blood vessel pat-
terns and may not bleed on touch. Irregular surface contour with a moun-
tains- and valleys- appearance is also characteristic of early invasive cancers. 
Such lesions frequently involve the endocervical canal and may obliterate the 
external os. Infiltrating lesions appear as hard nodular white areas and may 
present necrotic areas in the centre. Invasive cancers of the cervix rarely pro-
duce glycogen and therefore, the lesions turn mustard yellow or saffron yel-
low after application of Lugol’s iodine. Biopsy should be taken from the 
periphery of the growth, avoiding areas of necrosis, to ensure accurate histo-
pathological diagnosis. 
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There are no obvious colposcopic features that allow definite diagnosis of 
adenocarcinoma in situ (AIS) and adenocarcinoma, as no firm criteria have 
been established and widely accepted for recognizing glandular lesions(6,7). 
Most cervical AIS or early adenocarcinoma is discovered incidentally after 
biopsy for squamous intraepithelial neoplasia. Glandular disease often goes 
unnoticed because of imperfect cytologic findings, including inadequate 
sampling and failed screening. There is also the challenge of mixed disease 
because the colposcopist is satisfied to have recognized a squamous lesion 
and not search for a coexisting glandular one (8,9). 48%of AIS lesions 
involve only one cervical quadrant versus only 10% occupyng four 
quadrants. The linear length of AIS disease usually does not exceed 15mm. 
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The accurate colposcopic diagnosis of preclinical invasive carcinoma and 
glandular lesions depends on several fact (10): 
• continuing alertness on the part of the colposcopist  
•  strict adherence to the step-by-step approach to examination,  
•  the use of a grading index,  
•  close attention to surface blood vessels  
•  the honest appraisal of when an examination is inadequate  
• the appropriate use of ECC to rule out lesions in the canal  
•  taking of a well directed biopsy of sufficient tissue on which to base 
a reliable histopathological diagnosis 
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